Skip to main content
. 2022 Jul 15;13(12):1504–1525. doi: 10.1039/d2md00143h

In vitro antibacterial activity of selected compounds against Gram-positive streptococci strains.

graphic file with name d2md00143h-u14.jpg
Compd R1 R2 X MICa (μg mL−1)
S. pneumoniae B0652 (eryS) S. pneumoniae B0326 (M) S. pyogenes B0542 (eryS) S. pyogenes B0545 (M)
12a H graphic file with name d2md00143h-u15.jpg NH 128 >128 16 8
12c OCH3 NH 32 128 16 8
15a H graphic file with name d2md00143h-u16.jpg NH 16 32 2 2
15b F NH 64 64 4 4
15c OCH3 NH 32 64 2 4
16a H graphic file with name d2md00143h-u17.jpg NH 32 64 4 4
16c OCH3 NH 64 64 4 4
17a H graphic file with name d2md00143h-u18.jpg NH 8 32 4 4
18a H graphic file with name d2md00143h-u19.jpg NH 128 128 8 8
18c OCH3 NH >128 128 16 16
21b F graphic file with name d2md00143h-u20.jpg S 32 128 32 128
AZM b 0.125 16 0.125 8
Ampicillin 0.25 0.25 0.25 0.25
a

Minimal inhibitory concentrations.

b

Azithromycin.